The Washington Post reports:
A three-judge panel of the conservative U.S. Court of Appeals for the 5th Circuit said Food and Drug Administration decisions to allow the drug mifepristone to be taken later in pregnancy, be mailed directly to patients and be prescribed by a medical professional other than a doctor were not lawful.
Despite the court’s ruling against the government and the drug manufacturer, mifepristone will remain available for now under existing regulations while the litigation continues, in accordance with a Supreme Court ruling this spring. Wednesday’s decision is likely to be appealed to the Supreme Court.
The lawsuit, was filed in Amarillo, Tex., where U.S. District Judge Matthew Kacsmaryk — a Trump nominee with long-held antiabortion views — is the sole sitting judge. He issued an unprecedented ruling, for the first time suspending FDA approval of a human drug over objections from the agency.
Read the full article.
Kacsmaryk, a former lawyer for an anti-LGBTQ hate group, was exposed in April for failing to disclose millions in stock holdings. Kacsmaryk was previously exposed for failing to disclose viciously anti-LGBTQ interviews and acting to hide his authorship of an anti-abortion article ahead of his Senate confirmation hearing.
Appeals court upholds some limits on abortion pill mifepristone, setting up high-stakes Supreme Court review https://t.co/a6wGvT8JBu
— The Washington Post (@washingtonpost) August 16, 2023
